Alector, Inc. (ALEC) vs Foghorn Therapeutics Inc. (FHTX)
Alector, Inc. and Foghorn Therapeutics Inc. are both Biotechnology companies. Alector, Inc. and Foghorn Therapeutics Inc. are of similar size ($214.4M and $213.8M). Foghorn Therapeutics Inc. grew revenue faster over the last twelve months: 52.0% against −82.9%. Foghorn Therapeutics Inc. has the higher net margin (−175.8% vs −850.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Foghorn Therapeutics Inc. leads on 12 and Alector, Inc. on 3.
Valuation
Profitability
| Metric | ALEC | FHTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (912.40%) | (198.04%) | 0.00% |
| Net margin | (850.13%) | (175.78%) | 0.00% |
| Free cash flow margin | (1,142.55%) | (229.49%) | 0.00% |
| Return on equity | (385.11%) | 81.90% | (57.72%) |
| Return on assets | (42.15%) | (30.06%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack